[Statins and cardiovascular disease prevention: use and prospective].
作者信息
Moulin P
机构信息
Service d'endocrinologie et des maladies de la nutrition, Centre de détection et de prévention de l'athérosclérose, Hôpital de l'Antiquaille, Lyon.
出版信息
Nephrologie. 2000;21(7):379-80.
PMID:11200617
Abstract
摘要
相似文献
1
[Statins and cardiovascular disease prevention: use and prospective].
Nephrologie. 2000;21(7):379-80.
2
[Treatment with statins for the reduction of cardiovascular risk].
Ital Heart J Suppl. 2001 Mar;2(3):221-3.
3
Statins & Alzheimer's.
Health News. 2000 Dec;6(12):1.
4
Will statins unseat estrogen?
Harv Heart Lett. 2000 Nov;11(3):1-4.
5
Pravastatin and coronary heart disease.普伐他汀与冠心病
N Engl J Med. 1999 Apr 8;340(14):1115-6; author reply 1116-7. doi: 10.1056/NEJM199904083401413.
6
Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.他汀类药物治疗对心血管死亡率和事件的一级预防：一项纳入超过65000例患者的网状Meta分析。
J Am Coll Cardiol. 2008 Nov 25;52(22):1769-81. doi: 10.1016/j.jacc.2008.08.039.
7
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.在常规临床实践中，与其他他汀类药物相比，瑞舒伐他汀治疗的老年患者的低密度脂蛋白胆固醇（LDL-C）水平及LDL-C达标情况。
Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94. doi: 10.1016/j.amjopharm.2007.10.002.
8
[Use of statins in primary prevention: from the theoretical presuppositions to complex scenarios of the real world].[他汀类药物在一级预防中的应用：从理论前提到现实世界的复杂情况]
G Ital Cardiol. 1999 Oct;29(10):1123-30.
9
The beneficial effects of HMG-coenzyme A reductase inhibitor in the primary and secondary prevention of atherosclerosis in the coronaries.
Prog Cardiovasc Nurs. 1996 Spring;11(2):38-9.
10
[Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
Med Clin (Barc). 1995 Nov 25;105(18):719.
Zotero 插件